Kimberly Stegmaier, M.D., James E. Bradner, M.D., Lisa R. Diller, M.D.

Location: Dana-Farber Cancer Institute - Massachusetts

Proposal: Therapeutic targeting of N-Myc with BET Bromodomain Inhibition in Neuroblastoma